UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial

British journal of cancer, 2006-10, Vol.95 (7), p.788-793

2006

Volltextzugriff (PDF)

Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC

Lung cancer (Amsterdam, Netherlands), 2005-04, Vol.48 (1), p.129-135

2005

Volltextzugriff (PDF)

Phase II Trial of Capecitabine and Vinorelbine as First-line Chemotherapy for Metastatic Breast Cancer Patients

Anticancer research, 2006-05, Vol.26 (3B), p.2451-2456

2006

Volltextzugriff (PDF)

High Complete Response in Advanced Nasopharyngeal Carcinoma With Bleomycin, Epirubicin, and Cisplatin Before Radiotherapy

JNCI : Journal of the National Cancer Institute, 1990-04, Vol.82 (7), p.616-620

1990

Volltextzugriff (PDF)

Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type

European journal of cancer (1990), 1992, Vol.28A (11), p.1792-1797

1992

Volltextzugriff (PDF)

Vinorelbine and Cisplatin in Advanced Squamous Cell Carcinoma of the Cervix: The South African Experience

Anticancer research, 2005-05, Vol.25 (3C), p.2489-2492

2005

Volltextzugriff (PDF)

P-439 Chemotherapy-radiotherapy multimodalities with vinorelbine-cisplatin for stage IIIB non small cell lung cancer patients (NSCLC pts): Results from a Morrocan Phase II trial

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S232-S232

2005

Volltextzugriff (PDF)

P-461 Modified weekly schedule of cisplatin-vinorelbine chemotherapy in stages IIIB-IV non small cell lung cancer (NSCLC). Preliminary results about 18 patients

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S237-S238

2005

Volltextzugriff (PDF)

Phase II study of sequential administration of vinorelbine -capecitabine combination followed by weekly docetaxel as first line chemotherapy for advanced breast cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.817-817

2004

Volltextzugriff (PDF)

Phase II study of sequential administration of vinorelbine -capecitabine combination followed by weekly docetaxel as first line chemotherapy for advanced breast cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.817-817

2004

Volltextzugriff (PDF)

Evaluation of vinorelbine (N) and trastuzumab (H) as first-line therapy for patients (pts) with HER2- positive metastatic breast cancer (HER2+ MBC): Impact on clinical response and cardiac function

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.636-636

2004

Volltextzugriff (PDF)

Evaluation of vinorelbine (N) and trastuzumab (H) as first-line therapy for patients (pts) with HER2- positive metastatic breast cancer (HER2+ MBC): Impact on clinical response and cardiac function

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.636-636

2004

Volltextzugriff (PDF)

Long term survival of vinorelbine (N) and trastuzumab (H) as first line therapy for HER2-positive metastatic breast cancer patients (HER2+MBC) (pts)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.587-587

2005

Volltextzugriff (PDF)

Nasopharyngeal carcinoma: A medical oncology viewpoint. The Gustave Roussy experience

Annals of oncology, 1990-07, Vol.1 (4), p.245-253

1990

Volltextzugriff (PDF)

Phase II of oral vinorelbine (NVB oral) in combination with Cisplatin (P) followed by NVB oral single agent as consolidation therapy in advanced non small-cell lung cancer (NSCLC): A Patient's Benefit Analysis

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7338-7338

2004

Volltextzugriff (PDF)

Phase II of oral vinorelbine (NVB oral) in combination with Cisplatin (P) followed by NVB oral single agent as consolidation therapy in advanced non small-cell lung cancer (NSCLC): A Patient's Benefit Analysis

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.7338-7338

2004

Volltextzugriff (PDF)

Pr3 ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I–III) non small cell lung cancer (NSCLC) patients (pts)

Lung cancer (Amsterdam, Netherlands), 2005-07, Vol.49, p.S3-S4

2005

Volltextzugriff (PDF)

Pre-operative chemotherapy with navelbine (N) and anthracycline in locally advanced breast cancer (LABC): A multicentric Egyptian phase II trial

European journal of cancer supplements, 2004-03, Vol.2 (3), p.128-128

2004

Volltextzugriff (PDF)

Vinorelbine (N) in combination with cisplatin (P) in South African patients with advanced cervical carcinoma

European journal of cancer (1990), 1999-09, Vol.35, p.S234-S234

1999

Volltextzugriff (PDF)

A multinational phase II study of Navelbine (N) and Herceptin (H) as first-line therapy for patients with HER2-positive metastatic breast cancer (HER2+ MBC)

European journal of cancer supplements, 2004-03, Vol.2 (3), p.127-127

2004

Volltextzugriff (PDF)

823 A full navelbine oral (NVB oral) treatment in combination with cisplatin (P) followed by NVB oral single agent as consolidation therapy in advanced non small-cell lung cancer (NSCLC)

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S247-S247

2003

Volltextzugriff (PDF)

Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site

Proceedings of the National Academy of Sciences - PNAS, 2015-05, Vol.112 (21), p.6625-6630

2015

Volltextzugriff (PDF)

Phase II trial of recombinant interferon gamma in refractory undifferentiated carcinoma of the nasopharynx

Head & neck, 1993-03, Vol.15 (2), p.115-118

1993

Volltextzugriff (PDF)

Dietary supplements and bariatric surgery

Critical reviews in food science and nutrition, 2023-10, Vol.63 (25), p.7477-7488

2023

Volltextzugriff (PDF)

Gut microbiota in bariatric surgery

Critical reviews in food science and nutrition, 2023, Vol.ahead-of-print (ahead-of-print), p.1-16

2023

Volltextzugriff (PDF)

1 – 25 von 422

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(345)
Mit Volltextzugriff
(364)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial

Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC

Phase II Trial of Capecitabine and Vinorelbine as First-line Chemotherapy for Metastatic Breast Cancer Patients

High Complete Response in Advanced Nasopharyngeal Carcinoma With Bleomycin, Epirubicin, and Cisplatin Before Radiotherapy

Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type

Vinorelbine and Cisplatin in Advanced Squamous Cell Carcinoma of the Cervix: The South African Experience

P-439 Chemotherapy-radiotherapy multimodalities with vinorelbine-cisplatin for stage IIIB non small cell lung cancer patients (NSCLC pts): Results from a Morrocan Phase II trial

P-461 Modified weekly schedule of cisplatin-vinorelbine chemotherapy in stages IIIB-IV non small cell lung cancer (NSCLC). Preliminary results about 18 patients

Phase II study of sequential administration of vinorelbine -capecitabine combination followed by weekly docetaxel as first line chemotherapy for advanced breast cancer

Phase II study of sequential administration of vinorelbine -capecitabine combination followed by weekly docetaxel as first line chemotherapy for advanced breast cancer

Evaluation of vinorelbine (N) and trastuzumab (H) as first-line therapy for patients (pts) with HER2- positive metastatic breast cancer (HER2+ MBC): Impact on clinical response and cardiac function

Evaluation of vinorelbine (N) and trastuzumab (H) as first-line therapy for patients (pts) with HER2- positive metastatic breast cancer (HER2+ MBC): Impact on clinical response and cardiac function

Long term survival of vinorelbine (N) and trastuzumab (H) as first line therapy for HER2-positive metastatic breast cancer patients (HER2+MBC) (pts)

Nasopharyngeal carcinoma: A medical oncology viewpoint. The Gustave Roussy experience

Phase II of oral vinorelbine (NVB oral) in combination with Cisplatin (P) followed by NVB oral single agent as consolidation therapy in advanced non small-cell lung cancer (NSCLC): A Patient's Benefit Analysis

Phase II of oral vinorelbine (NVB oral) in combination with Cisplatin (P) followed by NVB oral single agent as consolidation therapy in advanced non small-cell lung cancer (NSCLC): A Patient's Benefit Analysis

Pr3 ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I–III) non small cell lung cancer (NSCLC) patients (pts)

Pre-operative chemotherapy with navelbine (N) and anthracycline in locally advanced breast cancer (LABC): A multicentric Egyptian phase II trial

Vinorelbine (N) in combination with cisplatin (P) in South African patients with advanced cervical carcinoma

A multinational phase II study of Navelbine (N) and Herceptin (H) as first-line therapy for patients with HER2-positive metastatic breast cancer (HER2+ MBC)

823 A full navelbine oral (NVB oral) treatment in combination with cisplatin (P) followed by NVB oral single agent as consolidation therapy in advanced non small-cell lung cancer (NSCLC)

Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site

Phase II trial of recombinant interferon gamma in refractory undifferentiated carcinoma of the nasopharynx

Dietary supplements and bariatric surgery

Gut microbiota in bariatric surgery

Suchergebnisse filtern